| Medical Physiology | Lifetime | 61 | US 40 | 99.91 |
| Molecular Biology | Lifetime | 512 | US 320 | 99.75 |
| Epidemiology | Lifetime | 388 | US 204 | 99.51 |
| Surgery | Lifetime | 608 | US 331 | 99.43 |
| Cell Biology | Lifetime | 302 | US 178 | 98.50 |
| Endocrinology, Diabetes and Metabolism | Lifetime | 581 | US 311 | 98.16 |
| Clinical Biochemistry | Lifetime | 267 | US 128 | 95.38 |
| Biochemistry | Lifetime | 497 | US 230 | 92.60 |
| Endocrine and Autonomic Systems | Lifetime | 697 | US 348 | 84.67 |
| Medical Biochemistry | Lifetime | 681 | US 192 | 67.75 |
| Epidemiology | 2021-2025 | 650 | US 228 | 93.91 |
| Medical Physiology | 2021-2025 | 457 | US 167 | 93.36 |
| Metabolism, Diabetes, and Cancer | Lifetime | 1 | US 1 | 99.95 |
| Adipose Tissue and Metabolism | Lifetime | 2 | US 2 | 99.98 |
| Diet and metabolism studies | Lifetime | 11 | US 6 | 99.94 |
| Pancreatic function and diabetes | Lifetime | 10 | US 5 | 99.89 |
| Liver Disease Diagnosis and Treatment | Lifetime | 88 | US 32 | 99.84 |
| Muscle metabolism and nutrition | Lifetime | 41 | US 20 | 99.67 |
| Metabolism and Genetic Disorders | Lifetime | 100 | US 46 | 99.39 |
| Diet, Metabolism, and Disease | Lifetime | 57 | US 27 | 99.56 |
| Lipid metabolism and biosynthesis | Lifetime | 33 | US 16 | 99.24 |
| Peroxisome Proliferator-Activated Receptors | Lifetime | 64 | US 37 | 99.28 |
| Adipokines, Inflammation, and Metabolic Diseases | Lifetime | 89 | US 45 | 99.48 |
| Mitochondrial Function and Pathology | Lifetime | 167 | US 78 | 99.28 |
| Glycogen Storage Diseases and Myoclonus | Lifetime | 32 | US 16 | 99.02 |
| Metabolomics and Mass Spectrometry Studies | Lifetime | 172 | US 71 | 98.83 |
| Lipid metabolism and disorders | Lifetime | 156 | US 64 | 98.02 |
| Regulation of Appetite and Obesity | Lifetime | 331 | US 157 | 97.93 |
| Diabetes Treatment and Management | Lifetime | 693 | US 255 | 97.56 |
| Diabetes Management and Research | Lifetime | 855 | US 358 | 97.35 |
| Endoplasmic Reticulum Stress and Disease | Lifetime | 623 | US 281 | 96.31 |
| Blood transfusion and management | Lifetime | 719 | US 306 | 91.85 |
| Adipose Tissue and Metabolism | 2021-2025 | 81 | US 22 | 97.06 |
| Diet, Metabolism, and Disease | 2021-2025 | 251 | US 53 | 93.09 |
| Mitochondrial Function and Pathology | 2021-2025 | 877 | US 253 | 86.46 |
| Metabolism, Diabetes, and Cancer | 2021-2025 | 569 | US 149 | 85.87 |
| Adipokines, Inflammation, and Metabolic Diseases | 2021-2025 | 746 | US 146 | 79.01 |
| Lipid metabolism and biosynthesis | 2021-2025 | 572 | US 121 | 71.11 |
| Peroxisome Proliferator-Activated Receptors | 2021-2025 | 972 | US 176 | 57.65 |
| Cholesterol and Lipid Metabolism | 2021-2025 | 849 | US 150 | 52.19 |